© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
March 12, 2021
According to one new study, proton-pump inhibitors (PPI) exposure demonstrated a moderate increase in the risk of community-acquired C diff infection.
February 16, 2021
Clostridioides difficile thrives in an environment of inflammation which found that inflammation provides nutrients for C. diff and creates an inhospitable environment for competing bacteria.
February 15, 2021
Investigators said their paper was the first systematic review and meta-analysis of C diff infection diagnostic methods in Korea.
February 09, 2021
An orally administered adsorbent to prevent antibiotic disruption of intestinal flora enters phase 3 trial against clostridium difficile (C diff) in patients with hematologic malignancies.
February 06, 2021
Contemporary care guidelines for this bacterium in geriatrics needs to be followed more closely, one study found.
January 17, 2021
Empiric broad-spectrum antimicrobial therapy, including coverage of MRSA and Pseudomonas aeruginosa, is generally recommended for healthcare-associated infections.
January 15, 2021
The bowel resting strategy might reduce switching from metronidazole to vancomycin among patients with Clostridioides difficile infection, but it might not reduce mortality or recurrence, a new study found.
January 08, 2021
December 26, 2020
Biologics have become a novel treatment in recurrent C. difficile.
December 14, 2020
An investigational microbiome-based therapeutic for C difficile was found to exert continued efficacy 3 months after administration.